We are live on
!
Find out more
Two Sigma Investments Portfolio holdings
AUM
$124B
1-Year Est. Return
33.93%
This Fund
S&P 500
This Quarter
Est. Return
+9.67%
1 Year Est. Return
+33.93%
3 Year Est. Return
+96.56%
5 Year Est. Return
+105.93%
10 Year Est. Return
+538.88%
AUM
$42.6B
AUM Growth
-$927M
(-2.1%)
Cap. Flow
-$4.42B
Cap. Flow
% of AUM
-10.38%
Top 10 Holdings %
Top 10 Hldgs %
9.02%
Holding
3,518
New
408
Increased
1,022
Reduced
1,392
Closed
532
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$244M |
| 2 |
Pfizer
PFE
|
+$234M |
| 3 |
Nike
NKE
|
+$201M |
| 4 |
Tesla
TSLA
|
+$200M |
| 5 |
S&P Global
SPGI
|
+$196M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$305M |
| 2 |
Advanced Micro Devices
AMD
|
+$241M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$231M |
| 4 |
Merck
MRK
|
+$199M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.1% |
| 2 | Healthcare | 11.63% |
| 3 | Consumer Discretionary | 11.09% |
| 4 | Financials | 10.76% |
| 5 | Industrials | 9.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2351
Shore Bancshares
SHBI
$798M
| $443K | ﹤0.01% |
38,480
+21,555
| +127% | +$259K |
|
2352
Honda
HMC
$41.1B
| $439K | ﹤0.01% |
11,800
-1,300
| -10% | -$44.7K |
|
2353
Equity Lifestyle Properties
ELS
$12.6B
| $439K | ﹤0.01% |
6,810
-16,890
| -71% | -$1.13M |
|
2354
Regency Centers
REG
$13.9B
| $437K | ﹤0.01% |
+7,224
| New | +$447K |
|
2355
Ichor Holdings
ICHR
$2.5B
| $436K | ﹤0.01% |
11,300
-10,308
| -48% | -$399K |
|
2356
Upland Software
UPLD
$15.4M
| $436K | ﹤0.01% |
14,112
-6,384
| -31% | -$231K |
|
2357
Roivant Sciences
ROIV
$26.4B
| $436K | ﹤0.01% |
41,343
-172,557
| -81% | -$1.86M |
|
2358
Myriad Genetics
MYGN
$313M
| $435K | ﹤0.01% |
20,400
-16,800
| -45% | -$361K |
|
2359
Indivior Pharmaceuticals
INDV
$4.61B
| $434K | ﹤0.01% |
+20,263
| New | +$381K |
|
2360
Puma Biotechnology
PBYI
$447M
| $433K | ﹤0.01% |
81,694
-133,478
| -62% | -$719K |
|
2361
Village Farms International
VFF
$287M
| $432K | ﹤0.01% |
348,714
+163,951
| +89% | +$138K |
|
2362
Independent Bank Corp
IBCP
$843M
| $432K | ﹤0.01% |
17,031
-5,257
| -24% | -$131K |
|
2363
UFP Technologies
UFPT
$2.46B
| $429K | ﹤0.01% |
1,700
| – | – |
|
|
GDEN
2364
DELISTED
Golden Entertainment
GDEN
| $429K | ﹤0.01% |
11,640
+6,440
| +124% | +$238K |
|
2365
E.W. Scripps
SSP
$317M
| $429K | ﹤0.01% |
+109,068
| New | +$653K |
|
2366
Civista Bancshares
CIVB
$589M
| $428K | ﹤0.01% |
27,810
+5,775
| +26% | +$92.6K |
|
|
JBTM
2367
JBT Marel
JBTM
$6.33B
| $425K | ﹤0.01% |
4,055
-30,281
| -88% | -$3.02M |
|
2368
Ingevity
NGVT
$2.64B
| $425K | ﹤0.01% |
+8,900
| New | +$400K |
|
2369
NRC Health Common Stock
NRC
$453M
| $423K | ﹤0.01% |
10,686
-35,796
| -77% | -$1.42M |
|
2370
Repligen
RGEN
$9.29B
| $423K | ﹤0.01% |
2,300
+600
| +35% | +$114K |
|
2371
Federal Realty Investment Trust
FRT
$10.2B
| $420K | ﹤0.01% |
4,113
-10,098
| -71% | -$1.02M |
|
2372
Healthpeak Properties
DOC
$14.6B
| $419K | ﹤0.01% |
22,339
-69,961
| -76% | -$1.27M |
|
2373
Omnicom Group
OMC
$23.1B
| $417K | ﹤0.01% |
4,305
+5
| +0.1% | +$449 |
|
|
HAPN
2374
Happen Inc
HAPN
$2.25B
| $416K | ﹤0.01% |
47,348
-203,332
| -81% | -$1.7M |
|
2375
VanEck Mortgage REIT Income ETF
MORT
$369M
| $416K | ﹤0.01% |
+35,600
| New | +$403K |
|
Similar funds
VAM
Two Sigma Investments's Q1 2024 Portfolio in Review
As of Q1 2024, Two Sigma Investments held 3,518 positions worth $42.6B, down 2.1% from $43.5B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
Two Sigma Investments withdrew a net $4.42B in Q1 2024, closing 532 positions and reducing 1,392 holdings. Its most notable exit was Rivian, an estimated $158M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 18% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Two Sigma Investments opened a new position in Pfizer worth $234M.
- Two Sigma Investments's largest Q1 2024 buy was Pfizer: 8,419,014 shares worth $234M.
- Two Sigma Investments added most to Gilead Sciences in Q1 2024, an estimated $244M increase.
- Two Sigma Investments's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $305M.
- Two Sigma Investments fully exited Rivian in Q1 2024, selling an estimated $158M.
- Two Sigma Investments's ten largest holdings make up 9% of its $42.6B portfolio in Q1 2024.
- Two Sigma Investments opened 408 new positions and closed 532 in Q1 2024.
- Two Sigma Investments's portfolio value fell 2.1% quarter-over-quarter to $42.6B.
Based on Two Sigma Investments's 13F filing for Q1 2024, filed 15 May 2024.